Arnon Elizur

12PUBLICATIONS
15CO-AUTHORS
Food safety, traceability, certification and authenticityAllergyMedical physicsPsychosocial aspects of childbirth and perinatal mental healthAquaculture and fisheries stock assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 12, 2026
Cashew Reaction Thresholds, Its Predictors, and Very Low Validated Safe Doses, in a Large Allergic Population (Nut CRACKER Study).

|Nov 20, 2025
Decreased Severity of Oral Immunotherapy Induced Gastrointestinal Eosinophilic Reactions Following Revisions in Milk-Treatment Protocol.

Na'ama Epstein-Rigbi, Matan Elkan, Yair Tzarfati

|Jun 06, 2024
Target maintenance dose for peanut oral immunotherapy is 300 mg protein (or less): Pros and cons.

Julia Upton, Arnon Elizur

|Apr 13, 2024
Consumption of cow's milk formula in the nursery and the development of milk allergy.

Arnon Elizur, Shirel Rachel-Jossefi, Marianna Rachmiel

|Aug 22, 2023
Sesame eliciting and safe doses in a large sesame allergic population.

Liat Nachshon, Joost Westerhout, W Marty Blom

|Oct 03, 2022
Efficacy and safety of food allergy oral immunotherapy in adults.

Na'ama Epstein-Rigbi, Michael B Levy, Liat Nachshon

Pageof 2

Frequent Collaborators

8 joint publications

Liat Nachshon

5 joint publications

Naama Epstein-Rigbi

4 joint publications

Michael R Goldberg

2 joint publications

Benjamin Remington